CONFOSCREEN Trademark

Trademark Overview


On Friday, February 6, 2026, a trademark application was filed for CONFOSCREEN with the United States Patent and Trademark Office. The USPTO has given the CONFOSCREEN trademark a serial number of 79448224. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 16, 2026. This trademark is owned by Confo Therapeutics NV. The CONFOSCREEN trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Laboratory chemicals for scientific use; biochemicals for in vitro and in vivo scientific use; biochemical substances, namely antibodies for stabilization of proteins, all the aforementioned substances for scientific use and for use in laboratories; reagents for medical research; diagnostic preparations for scientific or research use; chemical reagents for use in genetic research; receptors and reagents for testing for G protein-coupled receptors (GPCRs); chemical substances for use in the production of drugs; biochemical and chemical substances and chemical reagents for measuring combined or divided natural and non-natural G protein-coupled receptors (GPCRs); proteins for use in science; chimeric proteins to measure, test and develop compounds and ligands binding to G protein-coupled receptors (GPCRs); cell-based assay systems for detecting G protein-coupled receptor activity, including binding assays capable of identifying low-affinity interactions and low molecular weight compound f...

Medical and pharmacological research services; pharmaceutical drug development services; laboratory research services relating to pharmaceuticals; research and development of vaccines and medicines; scientific research for medical purposes and the development of pharmaceutical preparations in the area of drugs interacting with G protein-coupled receptors (GPCRs); design of computer databases; updating of database software; data warehousing; provision of information and data relating to medical research and development; rendering of computer graphics featuring digital image correction for research and development; computer graphic design services featuring data and image processing services for making three-dimensional models; non-medical graphic design featuring digital imaging services; optical imaging for use in research and development of medicines; imaging via computers for use in research and development of medicines; graphic design services for generating and processing data and ...

Pharmaceutical and veterinary preparations for use in oncology and in the field of immunology, namely, pharmaceutical and veterinary preparations for treating immune-related diseases; pharmaceutical and veterinary preparations for the treatment of inflammatory diseases and infections and for the treatment of gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological and musculo-skeletal conditions and for the treatment of orphan diseases; chemical and biochemical substances for pharmaceutical and veterinary use in the nature of stabilized protein arrays, namely, small molecules and antibodies for diagnostic purposes for use in oncology and in the field of immunology and for the treatment of inflammatory diseases and infections; chemical and biochemical substances for pharmaceutical and veterinary use in the nature of stabilized protein arrays, namely, small molecules and antibodies for treatment of gastrointestinal, cardio...
confoscreen

General Information


Serial Number79448224
Word MarkCONFOSCREEN
Filing DateFriday, February 6, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, April 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesLaboratory chemicals for scientific use; biochemicals for in vitro and in vivo scientific use; biochemical substances, namely antibodies for stabilization of proteins, all the aforementioned substances for scientific use and for use in laboratories; reagents for medical research; diagnostic preparations for scientific or research use; chemical reagents for use in genetic research; receptors and reagents for testing for G protein-coupled receptors (GPCRs); chemical substances for use in the production of drugs; biochemical and chemical substances and chemical reagents for measuring combined or divided natural and non-natural G protein-coupled receptors (GPCRs); proteins for use in science; chimeric proteins to measure, test and develop compounds and ligands binding to G protein-coupled receptors (GPCRs); cell-based assay systems for detecting G protein-coupled receptor activity, including binding assays capable of identifying low-affinity interactions and low molecular weight compound fragments; biochemical substances for screening fragment-based and high-throughput chemical libraries; chemical substances for use in conformationally selective binding assays that predict biological activity of drug candidates.
Goods and ServicesMedical and pharmacological research services; pharmaceutical drug development services; laboratory research services relating to pharmaceuticals; research and development of vaccines and medicines; scientific research for medical purposes and the development of pharmaceutical preparations in the area of drugs interacting with G protein-coupled receptors (GPCRs); design of computer databases; updating of database software; data warehousing; provision of information and data relating to medical research and development; rendering of computer graphics featuring digital image correction for research and development; computer graphic design services featuring data and image processing services for making three-dimensional models; non-medical graphic design featuring digital imaging services; optical imaging for use in research and development of medicines; imaging via computers for use in research and development of medicines; graphic design services for generating and processing data and images for making three-dimensional models for use in research and development of medicines; scientific services relating to the development and application of proprietary G protein-coupled receptor screening technologies based on conformational selectivity; research and development of binding assays capable of predicting biological activity of drug candidates; development of advanced screening platforms for identifying therapeutic candidates targeting previously undruggable G protein-coupled receptors.
Goods and ServicesPharmaceutical and veterinary preparations for use in oncology and in the field of immunology, namely, pharmaceutical and veterinary preparations for treating immune-related diseases; pharmaceutical and veterinary preparations for the treatment of inflammatory diseases and infections and for the treatment of gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological and musculo-skeletal conditions and for the treatment of orphan diseases; chemical and biochemical substances for pharmaceutical and veterinary use in the nature of stabilized protein arrays, namely, small molecules and antibodies for diagnostic purposes for use in oncology and in the field of immunology and for the treatment of inflammatory diseases and infections; chemical and biochemical substances for pharmaceutical and veterinary use in the nature of stabilized protein arrays, namely, small molecules and antibodies for treatment of gastrointestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological and musculo-skeletal conditions and for the treatment of orphan diseases; veterinary products, namely, antibody reagents used for the detection of antigens in cells and tissue for medical purposes; veterinary products, namely, antibody reagents for therapeutic use in oncology and in the field of immunology and for the treatment of inflammatory diseases and infections and for the treatment of gastrointestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological and musculo-skeletal conditions and for the treatment of orphan diseases; veterinary products, namely, small molecules in the form of low molecular weight organic compounds; veterinary products, namely, biological preparations for use in oncology and in the field of immunology and for the treatment of inflammatory diseases and infections and for the treatment of gastrointestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological and musculo-skeletal conditions and for the treatment of orphan disease; diagnostic and therapeutic preparations based on single-domain antibodies for use in the treatment of orphan and rare diseases; pharmaceutical preparations for neurological disorders involving undruggable G protein-coupled receptor targets; biological preparations comprising stabilized G protein-coupled receptors for use in immunology and oncology; pharmaceutical preparations for use in identifying and validating novel agonists for G protein-coupled receptors; diagnostic agents for use in companion diagnostics involving G protein-coupled receptor-targeted therapies; pharmaceutical preparations for use in precision medicine targeting dynamic membrane proteins.

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, April 16, 2026
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 16, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 16, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameConfo Therapeutics NV
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBE

Trademark Events


Event DateEvent Description
Thursday, April 16, 2026SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, April 23, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 23, 2026APPLICATION FILING RECEIPT MAILED